SNPS Stock: Buy or Sell? Price Target & Forecast

SNPS Synopsys Inc As of Sep 3, 2026

$415.97

High-growth semiconductor IP & tools play; valuation stretched vs. earnings but supported by 15%+ revenue growth and strong margins.

Setup: Growth / Quality Confidence: 68 Horizon: 6-12 months Risk: medium-high Category: Large Cap Growth

🔒 Trade Plan — entry · target · stop

Entry Zone

$•••–•••

Target

$•••

Stop Loss

$•••

Risk / Reward

•.• : 1

Unlock the exact levels — free →

A free account reveals SNPS's entry zone, price target & stop loss. Full 1-week to 1-year price forecasts are included with Pro.

The Thesis

▲ Bull Case

15% revenue growth, 13.5% 5Y CAGR, 77% gross margin, 21% operating margin. Positioned in AI chip design wave; insider buying slight edge (72 vs 89 sells). Forward P/E 59x more reasonable than trailing 102x.

▼ Bear Case

Trailing P/E 102x, P/S 11x among highest for software. Price-to-FCF 70x elevated. Stock down 32% from 52W high ($616) despite flat earnings growth (8.5% YoY). Valuation leaves little margin for error if growth disappoints.

Valuation

OVERVALUED (on trailing earnings; fair on FCF and forward) — score 42/100

Trailing P/E 102x is in top 5% for software, but forward P/E 59x and strong revenue/margin profile justify a premium to S&P 500 (~20x). P/S 11x and EV/EBITDA 45x leave minimal margin of safety if growth falters. Price-to-FCF 70x suggests market prices in perfect execution.

Technical Levels

Support · $395.00 (Recent swing low / entry zone floor) · $375.00 (52-week low region ($366))

Resistance · $440.00 (Short-term cluster above current) · $500.00 (Psychological / prior breakout level) · $615.00 (52-week high; major resistance)

RSI: not available in dataset

Financial Health

Score 82/100. Strong liquidity (current ratio 1.62, quick ratio 1.53). High margins (77% gross, 21% operating) reflect software economics and pricing power. Debt metrics unavailable; recommend checking balance sheet for leverage. Overall financial position appears sound for a large-cap software/IP player.

Catalysts

Q earnings report & guidance	Next ~4-8 weeks (typical Q cadence)	HIGH — Earnings growth trajectory and forward guidance critical to valuation. Any miss on growth could trigger multiple compression.
AI chip design cycle strength / fab capex trends	Ongoing (watch NVIDIA earnings, TSMC capex commentary)	HIGH — Demand for SNPS tools hinges on customer capex cycles. Tailwind if AI demand sustains.
Memory-chip shortage resolution / 2027 scarcity outlook	Next 12-24 months	MEDIUM — If scarcity extends, design demand may stay robust. Resolution could cool upside.
M&A / Strategic partnerships	Ongoing (software consolidation trend)	MEDIUM — Industry M&A could boost or distort valuation.

Risk Flags

Valuation multiples (P/E 102x, P/S 11x) rank in top percentile; limited upside cushion if growth slows.

Price down 32% YoY from highs despite double-digit revenue growth; macro/sentiment headwinds may persist.

Forward guidance and near-term earnings revisions not available; earnings quality metrics (PEG, ROE, ROIC) missing from dataset.

Insider selling slightly exceeds buying (89 vs 72 over trailing period); no net conviction signal.

EV/EBITDA 45x is expensive for software, even accounting for growth; market repricing risk if rates stay high.

See SNPS's full trade plan — free

Create a free account to unlock the exact entry, target, and stop — plus run live analysis on any of 5,000+ tickers. No card required.

Unlock SNPS free →

More Analyses

TSLA

FTNT

NVDA

AAPL

MSFT

AMZN

SNPS FAQ

Is SNPS a buy right now?

Synopsys Inc's current read is a Growth / Quality setup with 68 confidence over a 6-12 months horizon. Valuation: OVERVALUED (on trailing earnings; fair on FCF and forward). See the full bull and bear case above, or run a live analysis for the exact entry, target and stop.

Is SNPS overvalued?

OVERVALUED (on trailing earnings; fair on FCF and forward) (valuation score 42/100). Trailing P/E 102x is in top 5% for software, but forward P/E 59x and strong revenue/margin profile justify a premium to S&P 500 (~20x). P/S 11x and EV/EBITDA 45x leave minimal margin of safety if growth falters. Price-to-FCF 70x suggests market prices in perfect execution.

What are the risks of buying SNPS?